UNRAVELLING THE COMPLEXITIES OF PATENT LAW IN INDIA: AN INSIGHT OVERVIEW

Shruti Mittal,

Vidyasthali Law College, Jaipur

ABSTRACT

Patent law as one of the crucial components of the belonging rights of highbrow, grants inventors different rights to their innovations developing technology. However, the legal regulation of patents is rather a branch that has many types of patents, including application, design, and plant ones, as well as many strict requirements for obtaining patents effective, for instance, novelty, non-obviousness, and application. Some of the activities include the applications, examinations, and ability disputes concerning the patent infringement and validity of the patent.

Furthermore, patent laws widely differ from one country to another creating a similar challenge for the international inventors. This is so due to the fact that technology itself follows a relatively fast pace, always requiring updating and relevance of the current legal trends in the field of patents. Knowing these subtleties will be vital to legal professionals,  inventors, inventors and policy makers to fulfill their goal in protecting their highbrow property and utilizing such to their advantage in a highly globalized market.

INTRODUCTION

Patent law is regarded as one of the fundamental branches of intellectual assets rights that aim at promoting innovation with the help of providing inventors special rights concerning their developments for a limited period of time. The famous one quote in this regard “ Respect for inventors is the key for success of a patent system”[i] was delivered to show the importance of patent rights and laws. Thus, patent regulation is directly in about encouraging individuals and corporate organizations to invest in research and development through the provision of legal protection against any form of use or exploitation of their creations.

This safety does not only encourage the disclosure of new technologies but also enable inventors to recover their costs and optimize their inventions. Patents normally regulate a area of creations that could be strict new, unnoticeable besides advantageous, endow inventors with the prospective to bar others from producing, utilizing, illustrate or importing their patented creation without their consent. However the exact extent of patent rights as well as their enforcement differs from country to country due to these financial, social, and technological differences. Patent structures rest on an important distribute of concessions and limitations that weigh how much of an innovation should be put into the market versus being locked away and how easily should understanding be accessible to instigate and property growth all over the world.

Unravelling the complexities of patent law demonstrates that is a biodimensional legal process influenced by the country’s own goals and policies, as well as its international commitments and social context. India is amongst the first few countries to adopt this system to award patents in accordance with the Patents Act of 1970, though over the years there has been transition with changes labored to meet the TRIPS standards. However the concept and realization of enforcement of patent law in India faces several issues; beginning from rigid patentability standards and lengthy periods of

examination procedures to strong and efficient opposition systems and great concern towards public interest especially in the pharmaceutical industry.

Thus, this insight overview seeks to demystify these complexities by presenting potential complexities that patent owners experience while dealing with the legal systems of India and assert their IPR’s.

Objectives of the Study

The following are the objectives of the research which discuss the purpose of the study:

a) To know the evolution of Patent Law

b) Understanding various challenges  arising from Patent Law of India

c) Understanding the hindrance of patent right enforcement in India

Relevance of the Study

In recent decade, the patent right become significant to most of all the persons in their professional life because of their artistic work and innovations which are further used by  various person because mostly are not aware of their rights. We discovered that the importance of this research is to examine the issues and reality of patent law. It will determine the actual complexities of the patent law in India in comparison to the other countries. This research will concentrate on deducing the reasons behind the complexities of patent law.

Literature Review

This paper explores the intricate landscape of patent law by outlining the challenges and problems faced through patent law. These complexities of patent law come in highlight with the help of some alike papers give the brief comparison between other international patents (Deepak Kumar Dash, Riya Vaiswade, Gayatri Gupta)[ii], some discuss the patent system benefits in digital era (  Xin Quyang, Zhen Shun, Xinzhen Xu)[iii] and some talked about the patent litigation ( Ms. Varada Jahagirdar, Ms. Akita Bansal)[iv]

Research Methodology

In order to complete the research, the researcher has employed the doctrinal method. The researcher has systematically explored the materials that are in the sphere of the legal articles, case laws, legislation, and other materials—to arrive at a decision and to assess whether or not the hypothesis is valid.

Hypothesis

1. The owning of patents in India is not as simple as it sounds because of the string connections that are internationally binding but nationally challenging.

2. The Indian patent law has been framed with the twin objectives of promoting innovation and public health specifically with regard to the pharmaceutical industry.

3. Several hurdles exist in executing the patent rights in India which are legal, procedural as well as infrastructural.

EVOLUTION OF PATENT LAW IN INDIA

The overall use of socioeconomically development and technological advancement for the purpose of patent laws in India is depicted by the changes in laws with time. In the beginning, it was governed under the Indian Patents and Designs Act of 1911, and the framework received a major change with the change undertaken by the Patents Act of 1970 when Ayyangar’s report was submitted in 1959 including recommendations for effectively evolutionary changes to the Patent Law prevalent in India[v], wherein the system patents over product patents in key sections within the pharmaceuticals and agrochemicals was prioritized to assure certain upper public obtain entry and to promote the domestic sectors. It actually came into force in 1972.

The need for similar reforms arose due to India’s accession to the WTO (World Trade Organization) and consequent obligation to follow the guidelines of the TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement. This led to a series of amendments made between 1999 and 2005 finalizing in the Patents (Amendment) Act in 2005 which extended product patent to every segment. It was to synchronise India’s patent legal frameworks with the global frameworks while addressing public concerns of health especially as evidenced by the amendment within the year 2013 of the Supreme Court in the Novartis case, which strengthened provisions for evergreening patents. New tendencies identification within the technique of improving the effectiveness of the patent tool through digitization and the usage of strategies for fast product examination alongside tasks to promote innovation and start-ups, stressing the continued lively stability between the safety of highbrow belongings and the fulfillment of public interest wishes.

KEY PROVISIONS OF INDIAN PATENT ACT

According to Patent Act, the patent refers to an exclusive right granted by the Government to the inventor to exclude others to use, make and sell an invention in a specific period of time.

An invention may be novel, inventive and industrial in the traditional sense while meeting all the modern criteria of protection as well applicability but it may not qualify for a patent under the following situations[vi]:

 1) an invention which is frivolous or which is for anything which is obviously opposed to a well  established natural laws [section 3(a)];

 2) an invention the exploitation of which might be deemed by the state: a) mainly for the purpose of national defense or national security, b) mainly for the private or individual use or gain or commercial used by individuals become opposed to public policy or morality or which leads to grave prejudice to the human, animal, plant or human health or to the environment we live in [section 3(b)];

 3) scientific principle or an abstract theory or idea, the invention of which is enough to qualify an applicant for a finding of non-obviousness outbreak of any living organism or formation of a non-organic compound found in nature [section 3(c)];

 4) the new appearance of a new form of a known substance which does not in turn lead to an increase in the already established virility of that substance or the mere discovery of any new property or of a new use for a known material, or discovery of the mere use that is contained in a known process, machine, or apparatus unless such known process yields a new product or contains at least one new reactant [section 3(d)];

The inventions relating to atomic energy are not patentable[vii]. There are mainly three types of patent recognized in India: Product Patents, Process patents and Patent for improvement or Design Patents.

CHALLENGES FACED IN PATENT LAW

Patent law is subjected to several complicated challenges that impact inventors, lawyers, and the rest of the community engaged in selling and protecting inventions. The Patent Act provide the subject matter in which patentibility of an invention become non patentable under Section 3 which are derivatives of pharmaceutical drugs, stem cells, diagnostic methods and kits, isolated DNA sequences and computer related inventions etc. [viii]

Some of the key challenges encompass are:

Complexity and cost of patent law  

Filing and maintaining patents may be astronomically expensive, particularly so for the independent inventor, and the small to medium-sized company. Subsequently, the patent application process in India holds certain difficulties because of a number of factors such as the protracted examination procedure, stringent criteria for the grant of patents and very efficient opposition procedures. There can be a delay in the examination process due to a large pendency at the Indian Patent Office and the necessity of the “Request for Examination” really can further prolong the process.

Further, India’s patent regime also has rigid standards especially for pharmaceuticals  under Section 3(d), which bars the patenting of new forms of known substances unless the enhancement in efficacy of the substance in question is proven to be extraordinary, and hence stifles incremental innovation. Moreover, the process takes longer because there can be pre-grant and post-grant opposition in which third parties can oppose the grant of the patent application adding more complexity and likely a longer time to it. Such factors give patent protection in India a longer and difficult process compared to any other country.

Moreover, the costs include the fees of the legal professionals, expenses for the software and the charges for renovation and  I also found that the  technique of applying for the business to involve quite extensive descriptions and highly specified claims about the business that need to be compliant with legal values.

Patent Quality and Examination

There is a patent blockage where delay is a common misery in the patent workplaces, majority of these places experience great backlogs, chiefly due to the delays in the examination procedures and casual informative exams are quite difficult, not mentioning terrific ones, including the fast-moving rate of technological changes and complicated contemporary inventions.

Patent Litigation and Enforcement

Cost is often very expensive and long drawn process which may stretch anywhere from several months to even years. The patent trolls that is NWT’s or nominally working towards entities, are entities that use the patent system with a view of acquiring patents and proceeding with litigation or demands for settlements more often than not hindering innovation.

Global Patent Protection 

It is the major challenge because across the different exceptional countries, the patent legal guidelines differ considerably, and it turns into challenging to create and enforce steady patent rights across the globe. Some of the difficulties that arise in making an attempt to harmonize patent legal guidelines round the globe contain variations in legislation Legal traditions, financial determination, and coverage goals.

Technological Advancements

It is considered itself a complexity. This kind of speedy flow of technology especially in the fields of software programs and the biotechnology fields and Artificial Intelligence is beyond the rate which law of patent can adapt itself to. Finding out the current corporation of recent technology which contains algorithms and genetic changes presents existent legal and ethical issues.

Patent infringement and Counterfeiting

Preventing and addressing patent infringement, particularly in cyberspace and the global markets, is getting even more challenging. Even the presence of counterfeiting affects the value of patented innovations and, therefore, presents broad enforcement problems.

Balancing innovation 

Maintaining a balance in the defense of patent owners while at the same time ensuring the public is granted access to some significant technologies and indeed invaluable lifestyle-saving drugs is always a delicate task. Complex matrices of maintaining patents might hinder innovation by employing growth challenges to accessibility and ramping up the risks of litigation for newcomers.

It is establishing these demanding situations as needing constant work to enhance patent law, enhance patent workforce functioning, and proceed to strengthen cooperation among countries to construct a more effective and equitable patent system.

How the complexities of patent law is differ or difficult in compare to other countries?

Strict Patentability Criteria

The patent law of India is very restrictive in nature as it does not include all the artistic work and inventions as per Section 3 of the Indian Patent Act, 1970. This the main provision which is differ from the other countries as their scope of patent is very wide.. Also, India’s policy on pharmaceutical patents is very rigid; patents are not granted if the new product is only a new form of a known substance[ix], the new form must be more effective (Section 3(d)). This clause is especially directed, as it will be seen shortly, at combating the practice of so called ‘evergreening’ of patents.

On the other hand, the majority of the other nations, for example, the United States of America have rather liberal approaches to the criteria of patentability. For instance, in

the U. S. , business methods and software are the example of patentable subject matter under some circumstances, but the same is not true for India.

Compulsory license

Compulsory licensing is included in the Indian Patent Act, 2005 (amendment) empowered the government to allow the third party to manufacture the patented product or process in the view of public interest including, but not limited to, reasons

of public health. It was famously employed in the case of Bayer’s cancer drug called Nexavar when a compulsory license was issued to an Indian firm to manufacture a copycat version[x]. Even though compulsory licensing is legal based on the TRIPS Agreement, the standard of issuing such licenses would differ. In many developed countries less frequent use is made of this concept, and if reference is made to the use of the concept of compulsory licensing, then the conditions that were placed are much more severe.

Lengthy & Cumbersome Examination Process

Indian patent law allows for strong ways of filing objections on patents before grant of the patent as well as after grant of the patent. The pre-grant opposition enables any person to oppose the grant of a patent application anticipating that the invention will be detrimental to the public interest. The post-grant opposition must be done within a year from the time that the grant for the patent was made. This dual opposition system rises the bar for getting and protecting a patent in India considerably, whereas, countries like the U. S have other ways of opposing the grant of a patent for example the post-grant review or inter partes review, they do not have pre-grant opposition. 

However, post-grant opposition provided by the European Patent Office (EPO)  although the process and the basis of the oppositions are not the same. The search of patents in India can take a longer time when compared to other organizations because of the sheer number of cases and lack of adequate manpower and infrastructure.

Also, India has a process of deferred examination in which an application is examined upon filing of request for examination which can be up to 48 months from the date of filing. Indeed, in countries such as the U. S and Japan, the procedures for examination of patents are quicker. The European Patent Office (EPO) also sits at middle level and takes relatively less time in theirs; examination starts within 6 months to 1 year to a request.

Traditional knowledge & Biodiversity

Indian law is quite tough toward the patents connected to the traditional knowledge and bio resources. Some of the legal measures by which India safeguards its bio-diversity and traditional knowledge from getting patented in other countries are the Biological Diversity Act of 2002 and Traditional Knowledge Digital Library (TKDL).

These laws guard against cases of exploitation of the indigenous people and their resources. Although many countries have begun to realize the necessity of safeguarding traditional knowledge and bio-diversity, the Indian outlook is more integrated by virtue of it being an internalized process in their legal framework especially with reference to the western world where such procedures are still embryonic or are not as much a part of the patent laws regime as they are in the Indian scenario.

Extension of patent term

India does not allow any extension of the term of the patents beyond standard 20 years irrespective of the time that has been taken to obtain the regulatory clearance. On the other hand, places like the U. S and EU have provisions for regaining lost time that is time spent on the regulatory approval process particularly for pharmaceutical products.

Pharmaceutical patents & public health

Patents law of India has shifted towards health consideration and prominence of public health specially concerning the availability of medicines. A clear example can be seen in India where the Supreme court of India rejected a patent for the cancer - fighting drug Glivec under Novartis case[xi] by stating that Indian laws on patents’ protection does not allow extension of monopolistic right of medical valued inventions contrary to the interest of public health. Actually, in developed countries like the U. S and EU though public health is an important factor of consideration, the laws of patents are more inclined to side with the patent owners and may impose less restrictions as to the patenting of the pharmaceutical products.

Foreign Filing License

Under the Indian patent regime, it is mandatory that if the invention was conceived, made or developed in India, the applicant cannot file a patent application in any other country unless and until, he/ she obtains the Foreign Filing License (FFL) from the Indian Patent Office. This actually makes a formidable requirement for any multi-national organization wishing to invest in the Indian market. Other nations do not have such stringent regulations on additional filing for foreign patents though some like China have similar regulations.

IMPEDIENTS TO PATENT RIGHT ENFORCEMENT

Patent rights holder can enforce his rights in India either through civil courts. Nevertheless, there is no IP specialized courts established to handle the cases.[xii] 

Backlog and time for final choice

The fundamental task under administering patent rights is the time that a courtroom takes in reaching the last decision. A patent lawsuit in the main takes around 5 to 7 years to be subsequently concluded after trial only if challenged with the help of the other party. The Commercial Courts Act is helping to speed up the process with case control hearings, and to internationalized trials. Although, the cases on the docket of the court and the lack of judicial officers influence the time taken to make the last on a case.

Subject Court Experts

In accordance with the Section 115 of Indian Patent Act, it provides for the appointment of a systematic advisor to help the courts in presenting the evaluations on the technical aspects of a count. The provision has no longer been frequently used by the courts. The situation that a technical expert will be appointed in the patent infringement suits will now not only contribute to the improvement of the quality of the decision but also to the reduction of the time for each last choice.

Provision of Section 3 in Patent Act

Besides the provided stakes that align with the current international standards, section 3 of the Act incorporates new criteria in the assessment of an invention’s patentability. In other words, as it is written in Section 3 among other things, inventions that are derivatives of medical & surgical operations, farming, plants, and animals alone cannot be patented. Thus, these inventions are scrutinized more, and patent owners face more challenges with their patents.

RELEVANT CASE LAWS:

Inspite of this, a numerous case can be seen where the enforcement of patent right in India is not so well efficient. One is where the enforcement of a patent by Roche for its lung cancer drug, Erlotinib, against Cipla, an Indian pharmaceutical company that launched a generic version of the drug. Roche attempted to get an injunction order to restrain Cipla from manufacturing and selling the generica and deciding that Roche could not benefit from an interim injunction while the claim was brought on the Delhi High Court, Cipla was free to continue selling its generic version of the compound at stake. The decision to award the damages stemmed from the constitutional provision on public interest and the necessity of making affordable life saving products. The case at hand explained that the patent owners struggle to protect their rights in India especially when the interest of public health is in jeopardy[xiii]. 

This decision demonstrated the shortcomings of obtaining prompt and efficient protection of the patented inventions, especially when the generic producers Bt cotton seeds were patented by Monsanto, an American headquartered corporation in the business of dealing in agrochemicals and agricultural biotechnology.  Monsanto sued Nuziveedu Seeds quoting that they had infringed on their patent. But the Delhi High Court upheld a decision that the Monsanto Company’s Bt gene technology patent was not eligible under the Indian patent law[xiv]. The court excluded the stem actually of the seeds and thereby restricted Monsanto’s patent protection rights. The case highlighted the challenges of patents protection in India especially in agricultural sector where food security as well as rights of farmers affects patents protection.

The well known case is a good example on patent enforcement in India and more so on the enforcement of patents on digital and multimedia technologies. Challenges rose to bear on Dolby in establishing that Das Telecom was using its patented audio compression technology without a license because such cases demanded technical examination and witnesses that take time to be conducted. Somehow, Dolby was able to get an interim injunction. This is because enforcement of patent rights in the country and particularly against multinational firms such as Vodafone can be very expensive and time consuming hence illustrating the challenges that patent owners encounter within the Indian legal system.[xv]

The another case makes evident problems of enforcing patents in India and more so in the consumer electronics industry. Philips faced the major challenge in the DVD technology that was overcome by counterfeiting and piracy in India that made the company face hurdles in protecting its patents. It becomes very nearly impossible to enforce patents in such an environment because piracy is rife and it becomes hard to track all the perpetrators. Further, the legal process in Indian is time consuming and expensive for the patent holders get an injunction or any other remedy.[xvi]

The above cases depict how issues of public interest, access to essential medicines, and stringent criteria for patentability as well as provisions for compulsion to license, complicate patent enforcement in India. These can prove to be major challenges to the actualization of patent rights for the holders planning to assert their rights in the country.

CONCLUSION

It is conclude that the nature of the problems related to the regulation of patents reveals the challenges of the sources of innovation on the one hand and the various social demand on the other. Starting with the efforts of fine-tuning the necessities of patentability and finishing with the difficulty of managing international responsibilities and defending the pursuits of public health, patent legislation stands before numerous complex challenges. Challenges with regard to patent best, enforcement obstacles, and shifts in the technological environment constantly influence the felony setting. Some limitations are time-consuming and expensive application, the problem of enforcement, the existence such as patent trolls, and patent thickets. 

Nevertheless, the patent system remains on the reform and through the employment of new technology in the processes, the quality of the patents being granted is being enhanced. Maintaining the public interest along with the rights of inventors and businesses thus continues to be important in patent law as a means for continued workshop. Solving these factors involve constant change, effective polices and implementation mechanisms, and international governance. A practical patent gadget not simplest serves to guard and promote ownership of the rights within the intellectual belongings; however, it also turns into a key determinant of the industrial development of an international, advances studies and improvement and sparks technological improvements for the advantage of society as a whole.

The position of patent law in India establish the distinctiveness of India’s perspective on how to effectively protect new generation patents while promoting social justice for all citizens in economic integration. As is the case with several other countries across the world, India’s legal system complies with TRIPS Agreement and other internationally recognized treaties; however, the latter has prescribed stringent criteria of patentability, especially in sectors like pharmaceuticals where health of billion of people is a huge concern globally. The problems of lengthy examination procedures, strong opposition regimes, or even compulsory licenses make the world of patents even more complicated. But these subtleties also emphasize India’s intent on protecting the commerce from monopolizing, guaranteeing availability of goods and services, and safeguarding the indigenous knowledge. The fine details involved are significant for patentees to understand them and strategically manage the process of acquiring and protecting patents in India, which is why it is imperative to consider the country as a legal and tactical position.

REFERENCES

[i] Kalyan C. Kankanala, Fun IP, Fundamental of Intellectual Property 8 ( Literators Publishing 2012)

[ii]Deepak Kumar Dash, Riya Vaiswade, Gayatri Gupta, A review on the Indian patent systems and its implication on the pharmaceutical industry ( August 7 2024, 9: 14 PM) https://www.researchgate.net/publication/368357773_A_Review_on_the_Indian_Patent_System_and_Its_Implication_on_the_Pharmaceutical_Industry 

[iii] Xin Quyang, Zhen Shun, Xinzhen Xu, Patent system in the digital era- Opportunities and new challenges ( August 7 2024, 9: 21PM)  https://www.sciencedirect.com/science/article/pii/S2773067022000310

[iv] S. Varada Jahagirdar, Ms. Akita Bansal, Challenges in Patent Development and Patent Litigation in India ( August 7 2024, 9: 37PM)

https://amlegals.com/challenges-in-patent-development-and-patent-litigation-in-india/#

[v] Karnika Seth, History and Evoluiton of Patent Law- International & National Perspectives (Aug 7, 2024, 6:44PM),  https://www.karnikaseth.com/wp-content/uploads/history-and-evolution-of-patents1.pdf

[vi]  The Patent Act, 1970, S.3, No. 39, Acts of Parliament, 1970 ( India)

[vii]  The Patent Act, 1970, S.4, No. 39, Acts of Parliament, 1970 ( India)

[viii]  India: Challenges faced in the protection and enforcement of patent rights ( Aug. 7, 2024, 7:53PM),

https://www.managingip.com/article/2a5bsc7vmakvohn4kh3i8/india-challenges-faced-in-the-protection-and-enforcement-of-patent-rights

[ix] Rahul Dev, Comparative Study Between Indian & U.S. Patent Laws (Aug 7, 2024, 10: 11PM) https://patentbusinesslawyer.com/comparative-study-between-indian-us-patent-laws/#:~:text=India's%20patent%20laws%20do%20not,process%2C%20machine%2C%20or%20product.&text=India%20also%20doesn't%20allow,U.S%2C%20Software%20patents%20are%20granted.

[x]  Bayer Corporation v. Union of India, AIR(2014) 7 SCC 448

[xi]  Novartis v. Union of India, AIR (2013) SC1311

[xii]   India: Challenges faced in the protection and enforcement of patent rights, ( Aug. 8, 2024, 11:48AM) https://www.managingip.com/article/2a5bsc7vmakvohn4kh3i8/india-challenges-faced-in-the-protection-and-enforcement-of-patent-rights

[xiii] Cipla Ltd. v. F. Hoffmann- La Roche Ltd. v. Cipla Ltd., 148(2008)DLT598

[xiv] Monsanto Technology LLC v. Nuziveedu Seeds Ltd & ors., AIR (2019) SC559

[xv] Dolby Laboratories Inc. v. Das Telecom Pvt. Ltd. & ors., CS(COMM.) 410/2016

[xvi]  Koninklijke Philips v. Bhagirathi Electronics & Ors., CS(COMM.) 436/2017